Meet the Team

Avril Daly

Avril Daly is CEO of the patient-led global umbrella organisation, Retina International, which represents the voice of charities and foundations concerned with the promotion of retina research and related health policy in 43 countries.

Avril has worked in health policy for rare and common eye disease since 2000 and was CEO of the Irish NGO, Fighting Blindness for eight years. She was Chairperson of Rare Disease Ireland from 2006-2019. In 2009 she was elected to the Board of Directors of Rare Disease Europe – EURORDIS, and has been the organisations Vice-President since 2012.

In 2011 Avril was appointed by the Irish Minister for Health to a steering committee working towards the development of the Irish National Plan for Rare Diseases. The plan was published in 2014. She was appointed to the Irish Clinical Programme for Rare Diseases at the Health Service Executive (HSE) in Ireland in 2014 and was recently appointed to the Rare Disease Technology Review Committee and the National Centre of Pharmacoeconomics (NCPE) to review orphan therapies that fail initial Health Technologies Assessment (HTA) for statutory reimbursement.

Avril has held board positions with the European Patient Forum, The European Platform for Patient Organisation Science and Industry (EPPOSI), the HRCI (formerly Medical Research Charities Group) in Ireland and IPPOSI, the Irish Platform for Patients Organisation Science and industry. She believes that patients have a critical role to play in aiding the development of appropriate interventions from concept to delivery.

Avril holds a Bachelors Degree in Business and International relations, she is affected by Retinitis Pigmentosa.

Avril Daly, CEO

Dr. Orla Galvin
Director of Research Policy

Dr. Orla Galvin is the Director of Research Policy at Retina International.

Orla has led a first-in-kind pilot study in Ireland and the UK, to better understand the impact of Inherited Retinal Disease on patients and families in these countries through literature review, and patient and carer survey. The learnings from this work have proven invaluable and have guided Orla in directing additional projects assessing the patient/carer and clinical perspective in other retinal disease areas in other countries.

Orla serves on the organisation committee of the Retina Youth Programme for the Retina International World Congress 2022, and acts as an advisor to the Retina International Youth Council.

Orla believes in continuous education and raising awareness of retinal conditions. In 2017 Orla co-ordinated the University College Dublin Inherited Blindness Summer School; and in 2018 she designed and developed the content for the Diabetes-related Eye Disease toolkit which launched in January 2019. This educational site aims to provide timely, relevant and accurate information to patients and their families and professionals (Eye Care Professionals, Advocates, etc.) on Diabetes-related Eye Diseases (DEDs).

Orla is co-ordinator and moderator for the CME accredited Retina International ARVO 2020 education course on patient data “Patient Data: Recognition, Evaluation, Incorporation and Practice”. Orla took part in the first ever ARVO online event “Artificial Intelligence in ocular medicine: Seeing into the future” and is developing an education tool to create awareness of the advances and benefits AI can bring to the patient and to health care systems across the globe.

Orla came to Retina International with a background in academic and industry vision research. Orla is a Pharmacology graduate from University College Dublin with a PhD in Medicine from Queen’s University Belfast. Orla has won the Geraldine Duggan Young Investigator award and the SFI/TIDA venture training programme award.

During her postdoctoral career, including Wellcome Trust, and Marie Curie Fellowship positions, Orla’s research interests included drug discovery, design and delivery in academic and industry settings in Ireland and the UK. Orla continues to build upon her background in ocular therapy development, education, and inter-sector communication through Retina International, and believes optimal care and progress can be achieved through a multi-stakeholder approach.

Photo of Orla Galvin
Dr. Orla Galvin, Director of Research Policy

Fiona Waters
Community Engagement & Outreach Officer

Fiona Waters is the Community Engagement & Outreach Officer for Retina International and is presently based in Dublin, Ireland. Fiona’s focus is on fostering a proactive, global network of patients, clinicians, researchers, policymakers, and industry partners that are all aligned to a common goal; enabling those affected by retinal degenerations to live active and fulfilling lives.

Fiona has a strong background in fostering multi-stakeholder communities through science education, communication, and public engagement. Of note is her work as project coordinator for the innovative cross-disciplinary STE(A)M-education programme Quavers to Quadratics, which grew to a national level during her time with the project. Additionally, through her role of Public Engagement in Research Officer with Systems Biology Ireland, she acted as Interim Project Coordinator of AMGEN Biotech Experience Ireland, and created a bioinformatics module series for secondary level students, thus opening up the world of genomics to young adults. She has developed her ethos of creative, dynamic, and innovative solutions to science communication and public engagement through her sustained involvement with Science Gallery Dublin, where she has fulfilled the roles of Mediator, Research Assistant, and member of the SGD Youth Advisory Committee.

Fiona has a degree in Molecular Medicine from Trinity College Dublin, and her education has allowed her to be a more active agent of her own health and wellbeing. She believes that everyone, especially those affected by lifelong medical conditions, should be afforded the same level of empowerment, and is committed to bringing this to the Retina International community.

Fiona Waters, Community Engagement & Outreach Officer

Petia Stratieva, MD/Ph.D.
Special Project Manager

Petia Stratieva is Founder and Chairperson of Retina Bulgaria and a member of the ePAG at ERN-EYE.

Petia joins Retina International as an MD with a specialty in Immunology from the Medical University in Sofia, Bulgaria and holds a Ph.D. in Molecular Biology from the Shemyakin & Ovchinnikov Institute of Bio-organic Chemistry of the Russian Academy of Science in Moscow, Russia.

With over 10 years experience in Research and 20 years in the Pharmaceutical Industry in various managerial and multicultural roles and a strong focus on public & governmental affairs, policies implementation and people development, Petia offers a wealth of experience to the Retina International team.

Petia also has personal experience of living with Retinitis Pigmentosa, being diagnosed at the age of 25.

Petia Stratieva, MD/Ph.D. Special Project Manager

Kelly McVicker

Kelly McVicker is the Administrator for Retina International, based in the Dublin office.

Kelly has been in the charity sector for over 8 years providing support to clients and members alike.

Her previous roles have included working for Active Retirement Ireland and Dublin Simon Community. Initially working in donor care, her growth in her role has now allowed her to work in Communications, Fundraising, Member Support and also aspects of Finance. Her enjoyment of the sector has allowed her main focus has been on member’s communication and maintenance of information, striving to bring better facilities and understanding to the charity sector to those that need it.

Kelly McVicker, Administrator

Meet our Board of Directors

The Board of Directors are elected from the delegates at the General Assembly and work with the President and the CEO on the development and implementation of the Retina International strategic development plan.

The Board also promotes the creation of societies run by individuals with retinal dystrophies for individuals with retinal dystrophies in countries where none exist. They also represent member societies collectively to supra-national bodies and work on the policy and issues determined by the GA.

Board of Directors Members are:

  • Franz Badura – Chairperson (ProRetina Deutschland)
  • D’Souza Jeremy (Retina Australia)
  • Holahan Ronan (Foundation Fighting Blindness Ireland)
  • Menzo Jason (Foundation Fighting Blindness USA)
  • Medefindt Claudette (Retina South Africa)
  • Morita Saburo (Japanese RP society)
  • Ramshage Caisa (Swenska RP-Föreningen)
  • Sánchez González David (FARPE)
  • Smedstad Martin (RP-foreningen i Norge)
  • Sutter Penz Marina (Retina New Zealand)

Scientific & Medical Advisory Board (SMAB)

The SMAB is composed of scientists nominated from each member organisations’ scientific & medical advisory boards.

Its purpose is to

  • help national research efforts to produce the best possible results through the exchange of information and co-operation
  • inform and advise Retina International and national Retina International member societies in medical and research matters

SMAB Members

Prof. Eberhart Zrenner
University Eye Hospital, Tübingen

Prof. Dr. Joe G. Hollyfield
The Cleveland Clinic Foundation, Cleveland, USA

Prof. Gerald J. Chader
Doheny Eye Institute, Los Angeles, CA, USA

Prof. MD Erica Fletcher
University of Melbourne

Dr. Michael Kalloniatis
University of New South Wales, Sydney

Prof. Bart Leroy

Ghent University & Ghent University Hospital

Dr. Juliana Maria Sallum
Sao Paulo

Dr. Rosane Resende
Rio de Janeiro

MD, FRCSC Ophthalmologist  Elise Heon
The Hospital for Sick Children, Toronto

Dr. Michael Cayouette
Intitut de recherches cliniques de Montreal

MD PhD Robert S. Molday
University of British Columbia, Vancouver

Xia Xiaoping
Zhongshan University, Guangzhou

Dr. Eeva-Marja Sankila
Helsinki University Eye Hospital, Helsinki

Prof. Hannu Uusitalo
Tampere University

Prof. Helene Dolfus
Hôpital de Hauttepierre

Prof. Dr. Isabelle Audo
Hôpital Quinzevingt

Prof. Dr. Eberhart Zrenner
Universitätsaugenklinik Tübingen

Birgit Lorenz
Uniklinikum Giessen und Marburg GmbH

Ass. Prof. Miltiadis K. Tsilibaris
University of Crete

Dr. Palimeris Gerasimos
University of Athens

Hong Kong
MD Stephen T.S. Lam
Clinical Genetics Service, Dept. of Health, Kowloon

Prof. She-ping Yip
The Hong Kong Polytechnic University, Kowloon

Prof. Einar Stefansson

University of Iceland, Reykjavik

Prof. Kristinn P. Magnusson
University of Iceland, Reykjavik

Dr. S. Natarajan
Aditya Jyot Eye Hospital, Mumbai

Prof. Peter Humphries

Trinity College, Dublin

Mr. David Keegan
Mater Misericordiae Hospital, Dublin

Prof. Francesca Simonelli
Universitâ Federico II, Napoli

Prof. Sandro Banfi
Telethon Institute of Genetics and Medicine, Napoli

MD,PhD Shuichi Yamamoto
Chiba University School of medecine, Chiba

Dr. Akira Murakami
Jyuntendo University School of Medecine, Tokyo

Dr. Caroline Klaver
Afd. Oogheelkunde, Erasmus MC, Rotterdam

Dr. Arthur A.B. Bergen
The Netherlands Ophthalmic Research Institute, Amsterdam

New Zealand
Rachel Barnes
University of Auckland

Assoc. Prof Andrea Vincent

MD, PhD. Cecilie Bredrup
Haukeland University Hospital, Bergen

Ragnheidur Bragadóttir
Ulleval University Hospital, Oslo

Josephine Prener Holtan
Ulleval University Hospital, Oslo

Prof. Dr. M Shakaib Anwar
Islamabad, Pakistan

South Africa
Dr. Susan Williams
University of the Witwatersrand

Prof. Raj Ramesar
UCT Medical School, Cape Town

Prof. Nicolas Cuenca Navarro
Universidad de Alicante

Dr. Isabel Pinilla Lozano
Institudo Aragones de Ciencias de la Salud

MD. PhD.  Carmen Ayuso
University Hospital Fundación Jiménez Díaz

Prof. Sten Andréasson
University of Lund

Prof. Fredrik Ghosh
University of Lund

Prof. Christina Grimm
University of Zürich

Prof. Francis Munier
Clinique ophthalmique universitaire, Lausanne

United Kingdom
Prof. Susie Downes
University of Oxford

Prof. Carmel Toomes
University of Leeds

Prof. MD Michael Cheetham
University College London

Prof. Dr. Joe G. Hollyfield
The Cleveland Clinic Foundation, Cleveland, USA

Prof. Gerald J. Chader
Doheny Eye Institute, Los Angeles, CA, USA

Dr. Brian Mansfield
The Foundation Fighting Blindness, Owings Mills

MD. PhD. Eric Pierce
Harvard Medical School


To keep up to date with our news and activities,
please leave your details below

Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.